Systems Biology Platform		BG Medicine leads these important initiatives:		Products
Metabolomics Proteomics Data Analysis and Interpretation		Leading an FDA Critical Path Initiative to discover new biomarkers of liver toxicity. Leading a pre-competitive approach to solve the leading cause of heart attacks. Visit HRP website by clicking here... Conducting a biomarker discovery project for TB drug development, in collaboration with the TB Alliance.		Cardiovascular Disease Cancer CNS Other